Market Overview
Global Depth of Anesthesia Monitoring Devices market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
Anesthetic depth is the extent to which the central nervous system (CNS) is depressed by a general anesthetic drug, relying on the strength of the anesthetic drug and the dose at which it is administered. Depth of anesthesia monitoring devices assists in personalizing anesthesia by permitting or enabling drug administration against the estimated state of waking up or arousal of a patient.
Market Scope
| Metrics | Details |
| CAGR | YY% |
| Market Size Available for Years | 2022-2031 |
| Estimation Forecast Period | 2024-2031 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Technology, Device Type, Application, End User |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report – Request for Sample
Market Dynamics: Drivers & Restraints
Growth in the Number of Surgeries Conducted
The growth in the number of surgeries conducted, particularly plastic and reconstructive procedures is expected to boost the need for depth of anesthesia monitoring devices. For instance, according to the International Society of Plastic and Aesthetic Surgeons (ISAPS) statistics, more than 1.8 million aesthetic procedures were conducted all over the globe in 2020.
Also, according to the American Society of Plastic Surgeons (ASPS), more than 28,076 buttock augmentation and over 299,715 breast augmentation procedures were conducted in the U.S. independently in 2019. Annually, roughly 8.6 million fractures are induced by osteoporosis around the globe. Females are additionally likely to suffer from this condition. For instance, the International Osteoporosis Foundation assessed that 75 million individuals in Europe, the United States, and Japan suffer from osteoporosis.
Furthermore, the technological advancements, rise in research activities, increaseing investments and growing awareness are among the other additional factors boosting the global market growth during the forecast period.
Lack of Anesthetists
The lack of anesthetists is expected to hamper the global market growth during the forecast period. For instance, according to the Anaesthetic Workforce: UK State of the Nation Report February 2022, there is presently a lack of at least 1,400 anesthetists across the UK, severely restricting the capability of the NHS to conduct procedures and handle the backlog. Furthermore, the high cost, stringent regulatory bodies, and high development costs are other additional factors hampering the global market growth during the forecast period.
Segment Analysis
The global depth of anesthesia monitoring devices market is segmented based on technology, device type, application, end user and region.
Bispectral Index Technology Segment is Expected to Dominate Market
Owing to new product approvals in the bispectral index technology segment and advancements the segment is expected to dominate the global market during the forecast period. For instance, in September 2023, BPH Energy’s investee corporation Cortical Dynamics obtained 510(k) authorization from the US Food and Drug Administration (FDA) for its Brain Anaesthesia Response Monitor (BARM) system version 1.
Moreover, in anesthesiology, similar to other medical fortes, clinicians seek to sustain patient safety and enhance results. Some anesthesiology specialists are examining how cutting-edge technologies such as artificial intelligence (AI) and machine learning (ML) may favorably affect the domain. Investigation into AI’s clinical applications and present restrictions in anesthesiology exercise indicates that these implements may exhibit utility in diverse domains, including depth of anesthesia monitoring, management of anesthesia, event and hazard prognosis, ultrasound direction, pain management, and operating room logistics.
Geographical Analysis
North America is Expected to Dominate the Global Market
Owing to the increasing cases of chronic disorders in North America the region is expected to dominate the global market during the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC) in October 2022, every 40 seconds, someone suffered from a heart attack, and almost 805,000 individuals in the United States have a heart attack annually.
Therefore, with an upsurge in surgeries due to chronic conditions, the market for anesthesia monitoring devices is probable to grow thereby dominating the market. Moreover, frequent approvals and launches in North America are also expected to drive market growth. For instance, in February 2022, Masimo obtained FDA authorization for SedLine’s state-of-the-art depth of anesthesia monitoring for usage on individuals as young as 1 year aged in the United States.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on the healthcare industry, particularly on elective procedures. Unfortunately, bariatric and metabolic surgery (BMS) have been hit the hardest. Many centers have halted referrals and procedures, which has led to a decrease in demand for depth of anesthesia monitoring devices, negatively impacting the global market growth during the forecast period.
Key Developments
- In February 2023, Medasense Biometrics Ltd. obtained the U.S. Food and Drug Administration (FDA) commercialization permission to the PMD-200 patient monitor with NOL technology designed for monitoring nociception (the physiological response to pain) via the De Novo premarket assessment course.
- In April 2022, GE Healthcare obtained the FDA pre-market authorization (PMA) for its End-tidal (Et) Control Software purposed for general anesthesia delivery on its Aisys Cs2 Anesthesia Delivery System. The Et control software semi-automates the delivery of anesthesia utilizing software, permitting anesthesia providers to fix marks for end-tidal oxygen and anesthetic drugs. The product enhances anesthesia delivery precision and streamlines workflows.
- In November 2021, MDoloris Medical Systems obtained regulatory approval for its HFVI MOC-9 high-frequency variability index monitor in Japan. The HFVI MOC-9 technology is the foremost monitoring solution for individuals experiencing analgosedation and anesthesia.
Competitive Landscape
The major global players in the market include GE HealthCare, Medtronic plc, Nihon Kohden Corporation, Koninklijke Philips N.V., Masimo, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., ConvaTec Group PLC, Medasense Biometrics Ltd., Spacelabs Healthcare and CNSystems Medizintechnik GmbH among others.
Why Purchase the Report?
- To visualize the global depth of anesthesia monitoring devices market segmentation based on technology, device type, application, end user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of depth of anesthesia monitoring devices market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global depth of anesthesia monitoring devices market report would provide approximately 69 tables, 72 figures and 194 pages.
Target Audience 2025
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
